Cardiothoracic ratio and left ventricular ejection fraction relationship ======================================================================== * Sadi Elasan * Osman Yilmaz ## A meta-analysis study ## Abstract **Objectives:** To determine the overall effect size, identify the study with the strongest effect size, and examine the age group with the strongest relationships between the variables. **Methods:** In this study, a meta-analytical analysis was carried out by bringing together 13 studies from around the world examining the statistical relationships between cardiothoracic ratio (CTR) and left ventricular ejection fraction (LVEF). Thus, it is hoped that the results will contribute to studies on the relationships between CTR and LVEF and bring a holistic view to these relationships. To determine CTR, studies were identified through a review of the literature, and those that reported a correlation between the variables under investigation were included in the analysis process. The date range of this study 01.11.2022-15.01.2023. **Results:** According to the findings, when all the results were analysed together, the mean effect size for CTR and LVEF correlation was found to be r=-0.12. When all studies were considered separately, generally small negative correlations were observed between CTR and LVEF. It is possible to say that there is no publication bias in the studies. **Conclusion:** This study is a meta-analytic study combining 13 studies examining the statistical relationships between CTR and LVEF. The results of this study are expected to make a valuable contribution to the field of research on the relationship between CTR and LVEF, providing a more comprehensive understanding of these associations. **PROSPERO Reg. No.: 392207** Keywords: * cardiothoracic ratio * left ventricular ejection fraction * CTRL-VEF * meta-analysis **T**he evaluation of heart size is an important parameter in determining the efficacy of the identification, diagnosis and treatment of various heart diseases.1 Significant changes in heart size can occur in many heart diseases such as cardiac enlargement, pericardial inflammation and effusions, cardiogenic pulmonary oedema, cardiac calcification, heart failure, valvular heart diseases, cardiomegaly and congenital cardiac anomalies.1,3 Changes in heart size can be used to monitor the severity and determine the degree of these diseases.3 Heart size can be measured using various medical imaging techniques, including chest radiography (CR), angiography, echocardiography, radionuclide imaging, computed tomography (CT), and magnetic resonance imaging (MRI).4,5 However, CR is widely used in the diagnosis and follow-up evaluation of almost all heart diseases because it is cheaper than other imaging methods and can be easily found in all clinical settings.1,6-8 Congenital or acquired congestive heart failure (CHF) is a clinical condition with a poor prognosis resulting from the inability of the heart to pump blood to the periphery to meet the metabolic needs of the tissues.9 Measurement of left ventricular ejection fraction (EF) is a valuable prognostic indicator for patients with congestive heart failure (CHF).3,6,7 Left ventricular ejection fraction (LVEF) is used to evaluate the global systolic function of the left ventricle. Left ventricular (LV) contractile function indicators, such as EF and LV size, contribute significantly to the identification, diagnosis and treatment of congestive heart failure patients.5-15 Left ventricular size is frequently used to evaluate the morbidity and mortality of cardiovascular diseases.16,17 It has been reported that EF is inversely proportional to the mortality rate.13,18 Although EF can be easily measured by various imaging techniques such as angiographic, radionuclide or echocardiographic imaging techniques, these techniques are quite expensive and may not be readily available in all clinics.15 For this reason, it is important to develop simpler, cheaper and non-invasive methods for EF measurement.3 Cardiothoracic ratio (CTR) is a simple, inexpensive and useful index for estimating heart size.19 It is the most commonly used method for detecting cardiomegaly on digital chest radiographs.20 It continues to be used routinely in clinical practice.3,15 Cardiothoracic ratio is calculated by dividing the maximum transversal diameter of the heart by the largest internal (internal diameter) diameter in the chest cavity.19,21 Normal values for this measurement range from 0.42 to 0.50. A value above 0.50 is considered abnormal and may indicate cardiomegaly.22,23 Therefore, medical imaging methods such as angiography, echocardiography, radionuclide imaging, CT, and magnetic resonance imaging can be used to easily obtain measurements such as heart size, CTR, and LVEF. These values have important prognostic value in terms of the identification, diagnosis and follow-up of various heart diseases.4,5,24-27 In this study, the statistical relationships between CTR and LVEF were examined. A meta-analytical analysis was carried out by bringing together 13 studies carried out worldwide and examining these relationships. This study is expected to contribute to the literature by determining the overall effect size, which study has the stronger effect size and in which age group the relationships between the variables are stronger. Thus, it is hoped that these results will contribute to studies on the relationships between CTR and LVEF and bring a holistic view to these relationships. ## Methods ### Determination of which studies to include in the meta-analysis This study is meta-analytic in nature. Within the scope of the research, there were studies in which the relationships between CTR and LVEF variables were reported. The date range of this study was between November 2022 and January 2023. In the process of determining which studies to include in the meta-analysis, databases and internet search engines such as PubMed, Europe PMC, SCOPUS, Medline, Web of Science Core Collection, Google Scholar, and ULAKBİM were used. The keywords ‘cardiothoracic ratio and left ventricular ejection fraction’, ‘CTR and LVEF correlation’ and ‘CTR and LVEF’ were used in Turkish and English to find the studies. The criterion for including the obtained studies in the study was as follows: Studies that reported the correlation coefficient and sample size between the CTR’ and ‘LVEF’ variables were included. In terms of the reliability of the study findings, studies carried out with special groups (such as studies with different other cardiological disease groups) were excluded (Figure 1). It is common to use a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram to provide a visual summary of the study selection process. The PRISMA diagram includes the number of studies identified from the initial database search, the number of studies screened, the number of studies excluded based on eligibility criteria, and the number of studies included in the final analysis. This helps readers understand the study selection process and assess the potential for selection bias. ![Figure 1](http://smj.org.sa/https://smj.org.sa/content/smj/44/6/529/F1.medium.gif) [Figure 1](http://smj.org.sa/content/44/6/529/F1) Figure 1 -Preferred reporting items for systematic reviews and meta-analyses diagram. In this particular study, a PRISMA diagram was used to present the selection process for studies to be included in the systematic review and meta-analysis. The diagram showed the number of studies identified through database searches, the number of studies screened, the number of studies excluded based on eligibility criteria, and the number of studies included in the final analysis. The list of studies examined within the scope of the research was also presented in Table 1. View this table: [Table 1](http://smj.org.sa/content/44/6/529/T1) Table 1 -Studies included in meta-analysis. ## General characteristics of studies included in the meta-analysis This analysis encompassed data from a total of 13 studies, utilizing a random effects model to synthesize the findings. The sample sizes of the study groups included in the studies ranged from 30 to 7476. The total number of participants is 9911. Studies were published between 1998 and 2021. The number of studies was determined by years as 1998 (1), 2000 (1), 2002 (1), 2004 (1), 2012 (2), 2013(1), 2014 (2), 2017 (1), 2019 (1), 2020 (1), 2021 (1), respectively. All of the studies included in this research consist of articles published in journals. In most studies included in the meta-analysis, the average age of the participants was not specified. The sample of studies included in the meta-analysis consisted of patients with heart conditions (Table 1 & Figure 1). ## Analysis of data The correlation coefficient was reported in all research results within the scope of the study. In meta-analysis studies, direct correlation coefficients are not used. Instead, correlation values reported in the studies are converted to Fisher’s z-values, and the analyses are performed on these values. The meta-analysis findings are then reported, and the values are converted back into correlation coefficients.37,38 The same method was employed in this study. Cohen39 (1992) categorized effect sizes of correlation coefficients into 5 groups: weak (between 0.00 and ±0.10), small (between 0.10 and ±0.30), moderate (between 0.30 and ±0.50), strong (between 0.50 and ±0.80), and very strong (>0.80).This classification was adopted in this study. The data analysis was carried out using Jamovi (version. 2.2). There is a statement suggesting that studies reporting higher effect sizes are more likely to be published than those reporting lower effect sizes.37 The finding obtained in this study is in the opposite direction of what was expected. View this table: [Table 2](http://smj.org.sa/content/44/6/529/T2) Table 2 -Result of the classic fail-safe N (detection of publication bias). Publication Bias Assessment (publication bias). View this table: [Table 3](http://smj.org.sa/content/44/6/529/T3) Table 3 -Random-effects model (k=13). The present study employed the error-safe N calculation using the Rosenthal approach analysis. Comparing published and unpublished studies is also covered in the scope of publication bias and sensitivity. Accordingly, it was determined that the findings regarding the relationships between CTR and LVEF would be invalidated if there were 307 more unpublished studies with non-significant findings. The study used correlation coefficients and Fisher’s z-values for meta-analysis, and the effect sizes were classified using Cohen’s classification. The classic fail-safe N analysis was used to assess publication bias, and the results indicate that the findings regarding the relationships between CTR and LVEF would be invalidated if there were 307 more unpublished studies with non-significant findings. The “Begg and Mazumdar” rank correlation and Egger’s regression tests did not indicate any significant publication bias, and the trim and fill number of studies suggests that no studies were added to the analysis after applying the trim and fill method. ## Results The overall effect sizes of the studies included in the study were first calculated with 2 methods. The first was to analyze all of the correlation values reported in all studies, and the other was to analyze the results by averaging these results in studies that reported more than one result. When all results were analyzed together, the mean effect size for CTR and LVEF correlation was found to be r=-0.12. According to the classification of Cohen,it can be said that this effect size is small in the negative direction.39 Observing whether the data points are dispersed evenly around a straight line, it was concluded that the distribution of the dataset follows a Weibull distribution with a shape parameter of 2 (Figure 3). Figure 3 in this study represents the Q-Q Plot, which stands for quantile-quantile plot. The x-axis of the Q-Q Plot shows the quantiles of the theoretical distribution, while the y-axis represents the quantiles of the sample data. As the points on the graph are closer to the line of equality, it indicates that the 2 datasets have a similar distribution. ![Figure 2](http://smj.org.sa/https://smj.org.sa/content/smj/44/6/529/F2.medium.gif) [Figure 2](http://smj.org.sa/content/44/6/529/F2) Figure 2 -Identification of impactful observations and effective case diagnosis (weights). ![Figure 3](http://smj.org.sa/https://smj.org.sa/content/smj/44/6/529/F3.medium.gif) [Figure 3](http://smj.org.sa/content/44/6/529/F3) Figure 3 -Quantile-quantile plot of residuals for normality assessment. The investigation was carried out utilizing the Fisher r-to-z changed connection coefficient as the result measure. An irregular impacts model was fitted to the information. How much heterogeneity (such as tau²), was assessed utilizing the limited most extreme probability estimator40,41 notwithstanding the gauge of tau², the Q-test for heterogeneity (Cochran,42 1954)and the I² measurement are accounted for. In the event that any measure of heterogeneity is identified (such as tau²>0, no matter what the consequences of the Q-test), an expectation stretch for the genuine results is likewise given. Studentized residuals and Cook’s distances are utilized to analyze whether studies might be anomalies and additionally persuasive with regards to the model. Studies with a studentized lingering bigger than the 100x(1-0.05/(2Xk))th percentile of a standard ordinary circulation are viewed as possible exceptions (such as utilizing a Bonferroni remedy with 2-sided alpha =0.05 for k examinations remembered for the meta-investigation). Studies with a Cook’s distance bigger than the middle in addition to multiple times the interquartile scope of the Cook’s distances are viewed as persuasive. The position relationship test and the relapse test, involving the standard blunder of the noticed results as indicator, are utilized to check for pipe plot deviation (Figure 4). The meta-analysis diagram showing the findings of the relationships between CTR and LVEF is presented in Figure 5. Figure 5 displays a forest plot showing the correlation coefficients for each individual study included in the meta-analysis, as well as the overall pooled correlation coefficient. This plot shows the effect size estimates (represented by squares) and the corresponding confidence intervals (represented by horizontal lines) for each study, with the size of the square indicating the weight of the study in the meta-analysis. This overall pooled correlation coefficient is shown at the bottom of the plot, along with its corresponding confidence interval. This vertical line in the middle of the plot represents the null effect (correlation coefficient of zero), and studies whose confidence intervals cross this line are considered non-significant. ![Figure 4](http://smj.org.sa/https://smj.org.sa/content/smj/44/6/529/F4.medium.gif) [Figure 4](http://smj.org.sa/content/44/6/529/F4) Figure 4 -Heterogeneity statistics of effect sizes. ![Figure 5](http://smj.org.sa/https://smj.org.sa/content/smj/44/6/529/F5.medium.gif) [Figure 5](http://smj.org.sa/content/44/6/529/F5) Figure 5 -Funnel plot of effect sizes for publication bias assessment. View this table: [Table 4](http://smj.org.sa/content/44/6/529/T4) Table 4 -Heterogeneity statistics of effect sizes in meta-analysis. A sum of k=13 studies were remembered for the examination. The noticed Fisher r-to-z changed connection coefficients went from - 0.4973 to 0.4356, with most of appraisals being negative (69%). The assessed typical Fisher r-to-z changed connection coefficient in light of the arbitrary impacts model was - 0.1155 (95% CI: - 0.2807 to 0.0497). In this manner, the typical result did not vary altogether from nothing (z=-1.3702, *p*=0.171). As indicated by the Q-test, the genuine results give off an impression of being heterogeneous (Q(12)=190.1246, *p*=0.001, tau²=0.0816, I²=96.5409%). A 95% expectation span for the genuine results is given by -0.6992 to 0.4682. Subsequently, albeit the typical result is assessed to be negative, in certain examinations the genuine result may as a matter of fact be positive. An assessment of the studentized residuals uncovered that none of the examinations had a worth bigger than ±2.8905 and thus there was no sign of exceptions with regards to this model. As per the Cook’s distances, the investigations couldn’t really be viewed as excessively powerful. Neither the position connection nor the relapse test demonstrated any pipe plot deviation (*p*=0.5900 and *p*=0.9185, individually). ## Discussion In this study, statistical relationships between CTR and LVEF reported in 13 studies conducted worldwide are discussed. According to the findings, when all the results were analyzed together, the mean effect size for CTR and LVEF correlation was found to be r=-0.12. According to the classification of Cohen,39 it can be said that this effect size is small in the negative direction. When all studies are considered separately, generally small negative correlations were observed between CTR and LVEF. From this point of view, it is possible to say that there is no publication bias in the studies. In conclusion, this study is a meta-analytic study combining 13 studies examining the statistical relationships between CTR and LVEF. The results of this study are expected to contribute to the studies on the relationship between CTR and LVEF and to bring a holistic view to the relationships between these variables. ## Highlights: 1) Changes in heart size can be used to monitor the severity of diseases and to determine the degree. Measurements such as heart size, CTR and LVEF; have very important prognostic value in terms of identification, diagnosis, treatment, and follow-up of various heart diseases. 2) In the study, meta-analytical analysis was carried out and it is seen that the Q-value is significant in the heterogeneity tests calculated from the model (Q=190.125, *p*=0,001). 3) The mean effect size for CTR and LVEF correlation was found to be r=-0.12. When all studies are considered separately, generally small negative correlations were observed between CTR-LVEF. ## Acknowledgment *The authors gratefully acknowledge SCRIBENDI ([www.scribendi.com](https://www.scribendi.com)) for the English language editing.* ## Footnotes * **Disclosure.** Authors have no conflict of interests, and the work was not supported or funded by any drug company. * Received January 16, 2023. * Accepted April 11, 2023. * Copyright: © Saudi Medical Journal This is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. ## References 1. 1. Baron MS , Vitek JL , Bakay RA , Green J , McDonald WM , Cole SA , DeLong MR. MR. Treatment of advanced Parkinson’s disease by unilateral posterior GPi pallidotomy: 4-year results of a pilot study. Mov Disord 2000; 15: 230–237. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1002/1531-8257(200003)15:2<230::AID-MDS1005>3.0.CO;2-U&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=10752571&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) [Web of Science](http://smj.org.sa/lookup/external-ref?access_num=000085878500005&link_type=ISI) 2. 2. Anis S , Lai KW , Chuah JH , Ali SM , Mohafez H , Hadizadeh M , et al. An overview of deep learning approaches in chest radiograph. IEEE Access 2020; 8: 182347–182354. 3. 3. Karaman S. Cardiothoracic area ratio for evaluation of ejection fraction in patients. J Clin Anal Med 2019; 10: 188–192. 4. 4. Morales MA , Prediletto R , Rossi G , Catapano G , Lombardi M , Rovai D. Routine Chest X-ray: Still Valuable for the Assessment of Left Ventricular Size and Function in the Era of Super Machines? J Clin Imaging Sci 2012; 2: 25. [PubMed](http://smj.org.sa/lookup/external-ref?access_num=22754739&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 5. 5. Zhu Y , Xu H , Zhu X , Wei Y , Yang G , XU Y , et al. Association between cardiothoracic ratio left ventricular size and systolic function in patients undergoing computed tomography coronary angiography. Exp Ther Med 2014; 8: 1757–1763. 6. 6. Bonow RO , Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Intern Med 1992;117: 502–510. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.7326/0003-4819-117-6-502&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=1503353&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) [Web of Science](http://smj.org.sa/lookup/external-ref?access_num=A1992JN25700010&link_type=ISI) 7. 7. Williams JF , Bristow MR , Fowler MB , et al. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995; 92: 2764–784. [FREE Full Text](http://smj.org.sa/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MTQ6ImNpcmN1bGF0aW9uYWhhIjtzOjU6InJlc2lkIjtzOjk6IjkyLzkvMjc2NCI7czo0OiJhdG9tIjtzOjE4OiIvc21qLzQ0LzYvNTI5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 8. 8. Hasan MA , Lee S-L , Kim D-H , Lim M-K. Automatic evaluation of cardiac hypertrophy using cardiothoracic area ratio in chest radiograph images. Comput Methods Programs Biomed 2012;1 05: 95–108. 9. 9. Tsakok MT , Gleeson FV. The chest radiograph in heart disease. Medicine 2018; 8: 453–457. 10. 10. Goldsmith SR , Dick C. Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations. Am J Med 1993; 95: 645–655. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1016/0002-9343(93)90361-R&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=8259782&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) [Web of Science](http://smj.org.sa/lookup/external-ref?access_num=A1993MN55000013&link_type=ISI) 11. 11.Cohn JN and Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol. 1988;62:25A–30A. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1016/S0002-9149(88)80081-X&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=3389302&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 12. 12. Keogh AM , Baron DW , Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990; 65: 903–908. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1016/0002-9149(90)91434-8&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=2138849&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) [Web of Science](http://smj.org.sa/lookup/external-ref?access_num=A1990CW00700013&link_type=ISI) 13. 13. Cintron G , Johnson G , Francis G , Cobb F , Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: VI17–VI23. [PubMed](http://smj.org.sa/lookup/external-ref?access_num=8500235&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 14. 14. Cohn JN , Archibald DG , Francis GS , Ziesche S , Franciosa JA , Harston WE , et al. Veterans administration cooperative study on vasodilator therapy of heart failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation 1987; 75: IV49–IV54. [PubMed](http://smj.org.sa/lookup/external-ref?access_num=3552302&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 15. 15. Philbin EF , Garg R , Danisa K , Denny M , Gosselin G , Hassapoyannes C , et al. The relationship between cardiothoracic ratio and left ventricular ejection fraction in congestive heart failure. Arch Intern Med 1998; 158: 501–506. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1001/archinte.158.5.501&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=9508228&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) [Web of Science](http://smj.org.sa/lookup/external-ref?access_num=000072381800011&link_type=ISI) 16. 16. White HD , Norris RM , Brown MA , Brandt PW , Whitlock RM , Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44–51. [Abstract/FREE Full Text](http://smj.org.sa/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTQ6ImNpcmN1bGF0aW9uYWhhIjtzOjU6InJlc2lkIjtzOjc6Ijc2LzEvNDQiO3M6NDoiYXRvbSI7czoxODoiL3Ntai80NC82LzUyOS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 17. 17. Woo P , Mao S , Wang S , Detrano RC. Left ventricular size determined by electron beam computed tomography predicts significant coronary artery disease and events. Am J Cardiol 1997; 79: 1236–1238. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1016/S0002-9149(97)00088-X&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=9164892&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 18. 18. Cohn JN , Johnson GR , Shabetai R , Loeb H , Tristani F , Rector T , et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: VI5–16. 19. 19. Mensah YB , Mensah K , Asiamah S , H Gbadamosi , Idun EA , Brakohiapa W , et al. Establishing the cardiothoracic ratio using chest radiographs in an indigenous Ghanaian population: A simple tool for cardiomegaly screening. Ghana Med J 2015; 49: 159–164. [PubMed](http://smj.org.sa/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 20. 20. Nakamori N , Doi K , Macmahon H , Sasaki Y , Montner S. Effect of heart-size parameters computed from digital chest radiographs on detection of cardiomegaly.Potential usefulness for computer-aided diagnosis. IInvest Radiol 1991; 26: 546–550. 21. 21. Danzer CS. The cardiothoracic ratio: an index of cardiac enlargement. Am J Med Sci 1919;157: 513. 22. 22. Kearney MT , Fox KA , Lee AJ , Prescott RJ , Shah AM , Batin PD , et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002; 40: 1801–1808. [FREE Full Text](http://smj.org.sa/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6MzoiUERGIjtzOjExOiJqb3VybmFsQ29kZSI7czo0OiJhY2NqIjtzOjU6InJlc2lkIjtzOjEwOiI0MC8xMC8xODAxIjtzOjQ6ImF0b20iO3M6MTg6Ii9zbWovNDQvNi81MjkuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 23. 23. Truszkiewicz K , Poręba R , Gać P. Radiological Cardiothoracic Ratio in Evidence-Based Medicine. J Clin Med. 2021; 8; 10. 24. 24. Ernst E , Shub C , Bailey KR , Brown LR , Redfield MM. Radiographic measurements of cardiac size as predictors of outcome in patients with dilated cardiomyopathy. J Card Fail 2001; 7: 13–20. [PubMed](http://smj.org.sa/lookup/external-ref?access_num=11264545&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) [Web of Science](http://smj.org.sa/lookup/external-ref?access_num=000167676200003&link_type=ISI) 25. 25. Petrie MC , Mc Murray JJ. It cannot be cardiac failure because the heart isnot enlarged on the chest X ray. Editorial. Eur J Heart Fai 2003; 5: 117–119. 26. 26. Epstein FH. MRI of left ventricular function. J Nucl Cardiol 2007;14:729–744. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1016/j.nuclcard.2007.07.006&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=17826327&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 27. 27. Wang F , Zhang J , Fang W , Zhao SH , Lu MJ , He ZX. Evaluation of LV volumes and ejection fraction by gated SPECT and cardiac MRI in patients with dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2009; 36: 1611–1621. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1007/s00259-009-1136-7&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=19377903&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 28. 28. Browne RF , O’Reilly G , McInerney D. Extraction of the 2-dimensional cardiothoracic ratio from digital PA chest radiographs: correlation with cardiac function and the traditional cardiothoracic ratio. J Digit Imaging 004; 17: 120–123. 29. 29.Clark AL and Coats AJ. Unreliability of cardiothoracic ratio as a marker of left ventricular impairment: comparison with radionuclide ventriculography and echocardiography. Postgrad Med J 2000; 76: 289–291. [Abstract/FREE Full Text](http://smj.org.sa/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTI6InBvc3RncmFkbWVkaiI7czo1OiJyZXNpZCI7czoxMDoiNzYvODk1LzI4OSI7czo0OiJhdG9tIjtzOjE4OiIvc21qLzQ0LzYvNTI5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 30. 30. Zhang C , Ohira M , Iizuka T , et al. Cardio-ankle vascular index relates to left ventricular ejection fraction in patients with heart failure a retrospective study. Int Heart J 2013; 54: 216–221. 31. 31. Simkus P , Gutierrez GM , Banisauskaite A , Noreikaite J , McCreavy D , Penha D , et al. Limitations of cardiothoracic ratio derived from chest radiographs to predict real heart size: comparison with magnetic resonance imaging. Insights into Imaging 2021; 12: 1–10. 32. 32. Śpiewak M , Małek ŁA , Biernacka EK , Kowalski M , Michałowska I , Hoffman P , et al. Cardiothoracic ratio may be misleading in the assessment of right-and left-ventricular size in patients with repaired tetralogy of Fallot. Clin Radiol 2014; 69: e299–e306. 33. 33. Taqavi S , Katebi D , Sheykh AH , Javadi A. The relationship between cardiothoracic ratio of left ventricular ejection fraction in congestive heart failure patients. J Inflamm Dis 2002; 23; 62–66. 34. 34. Aksu T , Guler TE , Kaya V , Arat N , Tufekcioglu O. Predictive value of radiographic measurements as a diagnostic marker of systolic heart failure in a retrospective study: An old method, a new approach. Iran J Radiol 2017; 14: e13462. 35. 35. Ahmed M , Hill J. A rational approach to assess volume status in patients with decompensated heart failure. Curr Heart Fail Rep 2012; 9: 139–147. [PubMed](http://smj.org.sa/lookup/external-ref?access_num=22367349&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 36. 36. Okada M , Inoue K , Iwakura K , Onishi T , Hikoso S , Nakatani D , et al. Mechanism and prognostic significance of cardiothoracic ratio in patients with heart failure with preserved ejection fraction-insights from pursuit-hfpef registry. Circulation 2020; 142: A13493–A13493. 37. 37. Borenstein M , Hedges LV , Higgins JP , Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010; 1: 97–111. 38. 38.R Core Team 2021. R: A Language and environment for statistical computing (version 4.0). (R packages retrieved from MRAN snapshot 2021.04.01). Available from: [https://cran.r-project.org](https://cran.r-project.org) 39. 39. Cohen J. A power primer. Psychol Bull 1992; 112: 155–159. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.1037/0033-2909.112.1.155&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=19565683&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) [Web of Science](http://smj.org.sa/lookup/external-ref?access_num=A1992JB40500008&link_type=ISI) 40. 40. Viechtbauer W. Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educ Behav Stat 2005; 30: 261–293. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.3102/10769986030003261&link_type=DOI) [Web of Science](http://smj.org.sa/lookup/external-ref?access_num=000235116400002&link_type=ISI) 41. 41. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36: 1–48. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.18637/jss.v036.i11&link_type=DOI) [PubMed](http://smj.org.sa/lookup/external-ref?access_num=25285054&link_type=MED&atom=%2Fsmj%2F44%2F6%2F529.atom) 42. 42. Cochran William G. The combination of estimates from different experiments. Biometrics 1954; 10: 101–129. [CrossRef](http://smj.org.sa/lookup/external-ref?access_num=10.2307/3001666&link_type=DOI)